Skip to content

Diabetes, Insulin Resistance and Body Composition

The Correlation Between Diabetes, Insulin Resistance and Body Composition

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06724068
Enrollment
515
Registered
2024-12-09
Start date
2021-12-17
Completion date
2022-08-31
Last updated
2024-12-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insulin Resistance, Diabetes

Brief summary

The goal of this retrospective study is to learn about the correlation between diabetes, insulin resistance and body compositions. The main question\[s\] it aims to answer are: * \[The difference of body composition between the individuals of insulin resistance and diabetes\] * \[The effect of diabetes on body composition\]

Interventions

OTHERDiabetes,Insulin resistance,Control

This retrospective study uses medical records and diagnostic data from patients with type 2 diabetes and healthy controls obtained from Qianfoshan Hospital from2019 to 2022

Sponsors

Xuan Song
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

1. Adults aged 18 years and older. 2. Diagnosed with type 2 diabetes mellitus according to recognized diagnostic criteria. 3. Availability of complete body composition data (e.g., DXA measurements). 4. Documented HbA1c levels and other glycemic control data. 5. Continuous medical records available during the study period

Exclusion criteria

1. Presence of other severe metabolic diseases, such as liver failure or kidney failure. 2. Use of medications affecting muscle mass (e.g., glucocorticoids) for more than three months. 3. History of malignancy or ongoing treatment for cancer. 4. Missing critical research data (e.g., diabetes duration or HbA1c levels). 5. History of surgeries causing significant body composition changes (e.g., bariatric surgery).

Design outcomes

Primary

MeasureTime frameDescription
Prevalence of Sarcopenia in Diabetic PatientsRetrospective analysis of data collected between2019 and 2022The proportion of diabetic patients diagnosed with sarcopenia, assessed based on measurements of muscle mass, muscle strength, and physical performance. Sarcopenia will be defined according to AWGS 2019 and EWGSOP2

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026